CUDAROLIMAB
UNII DT958C4NWR

Substance Identification & Data

This profile provides standardized clinical and technical data for Cudarolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DT958C4NWR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2244739-29-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DT958C4NWR
CAS Registry Number
2244739-29-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CUDAROLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C158507
National Cancer Institute reference terminology for clinical and research data.
INN ID
11200
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cudarolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CUDAROLIMAB

Common Names & Synonyms

CUDAROLIMAB [INN]
CUDAROLIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN MONOCLONAL IBI101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI101 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HOMO SAPIENS MONOCLONAL ANTIBODY

Technical Codes

IBI101
IBI-101

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus